CVS Health Corp (NYSE:CVS) saw a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 14,420,741 shares, an increase of 35.1% from the January 15th total of 10,671,652 shares. Currently, 1.1% of the shares of the stock are sold short. Based on an average daily volume of 9,924,659 shares, the days-to-cover ratio is currently 1.5 days.
CVS has been the subject of several research analyst reports. ValuEngine upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a report on Tuesday, November 6th. Loop Capital set a $80.00 price objective on shares of CVS Health and gave the company a “hold” rating in a report on Wednesday, November 28th. Cantor Fitzgerald began coverage on shares of CVS Health in a report on Monday, November 26th. They issued an “overweight” rating and a $96.00 target price for the company. Royal Bank of Canada set a $100.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research note on Wednesday, November 7th. Finally, Goldman Sachs Group reaffirmed a “neutral” rating and issued a $87.00 target price on shares of CVS Health in a research report on Thursday, November 29th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and thirteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $91.79.
NYSE:CVS opened at $67.79 on Thursday. The stock has a market capitalization of $66.34 billion, a price-to-earnings ratio of 11.49, a price-to-earnings-growth ratio of 0.88 and a beta of 1.03. The company has a quick ratio of 1.94, a current ratio of 2.44 and a debt-to-equity ratio of 1.66. CVS Health has a 1 year low of $60.14 and a 1 year high of $82.15.
The business also recently declared a quarterly dividend, which was paid on Monday, February 4th. Investors of record on Friday, January 25th were issued a $0.50 dividend. The ex-dividend date was Thursday, January 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.95%. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.
In other CVS Health news, insider Larry J. Merlo sold 166,368 shares of the business’s stock in a transaction on Tuesday, January 8th. The stock was sold at an average price of $69.04, for a total transaction of $11,486,046.72. Following the completion of the transaction, the insider now owns 496,577 shares in the company, valued at approximately $34,283,676.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO David M. Denton sold 25,159 shares of the business’s stock in a transaction on Thursday, November 29th. The stock was sold at an average price of $80.13, for a total value of $2,015,990.67. Following the sale, the chief financial officer now directly owns 403 shares in the company, valued at $32,292.39. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 435,534 shares of company stock worth $29,245,258. 0.53% of the stock is currently owned by corporate insiders.
Several large investors have recently modified their holdings of the company. Brookmont Capital Management raised its position in CVS Health by 3.0% during the fourth quarter. Brookmont Capital Management now owns 5,184 shares of the pharmacy operator’s stock worth $340,000 after acquiring an additional 152 shares during the period. Avestar Capital LLC increased its position in CVS Health by 19.6% in the fourth quarter. Avestar Capital LLC now owns 951 shares of the pharmacy operator’s stock worth $57,000 after buying an additional 156 shares during the period. Clarus Wealth Advisors boosted its stake in CVS Health by 6.9% during the fourth quarter. Clarus Wealth Advisors now owns 2,456 shares of the pharmacy operator’s stock valued at $161,000 after buying an additional 158 shares in the last quarter. Griffin Asset Management Inc. raised its stake in shares of CVS Health by 1.4% during the 3rd quarter. Griffin Asset Management Inc. now owns 11,438 shares of the pharmacy operator’s stock worth $900,000 after purchasing an additional 160 shares in the last quarter. Finally, Adviser Investments LLC grew its holdings in CVS Health by 5.4% in the 4th quarter. Adviser Investments LLC now owns 3,163 shares of the pharmacy operator’s stock valued at $207,000 after buying an additional 162 shares during the last quarter. 87.22% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This news story was reported by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://transcriptdaily.com/2019/02/14/cvs-health-corp-cvs-sees-significant-increase-in-short-interest.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Read More: What is a Derivative?
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.